OPN4 and glaucoma: Importantly, this new PIPR quadrant stimulation paradigm can differentiate melanopsin dysfunction in glaucoma suspects and early glaucoma from healthy controls with fair and excellent diagnostic accuracy, respectively (Fig. 9).